Literature DB >> 19619343

The process of updating the National List of Health Services in Israel: is it legitimate? Is it fair?

Dan Greenberg1, Miriam I Siebzehner, Joseph S Pliskin.   

Abstract

OBJECTIVE: The Israeli National Health Insurance Law stipulates a National List of Health Services (NLHS) to which all residents are entitled from their HMOs. This list has been updated annually for almost a decade using a structured review and decision-making process. Although this process has been described in detail in previous papers, none of these have fully addressed legitimacy and fairness. We examine the legitimacy and fairness of the process of updating the NLHS in Israel.
METHODS: We assessed the priority-setting process for compliance with the four conditions of accountability for reasonableness outlined by Daniels and Sabin (relevance, publicity, appeals, and enforcement). These conditions emphasize transparency and stakeholder engagement in democratic deliberation.
RESULTS: Our analysis suggests that the Israeli process for updating the NLHS does not fulfill the appeals and enforcement conditions, and only partially follows the publicity and relevance conditions, outlined in the accountability for reasonableness framework. The main obstacles for achieving these goals may relate to the large number of technologies assessed each year within a short time frame, the lack of personnel engaged in health technology assessment, and the desire for early adoption of new technologies.
CONCLUSIONS: The process of updating the NLHS in Israel is unique and not without merit. Changes in the priority-setting process should be made to increase its acceptability among the different stakeholders.

Entities:  

Mesh:

Year:  2009        PMID: 19619343     DOI: 10.1017/S026646230999016X

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  8 in total

1.  Public legitimacy of healthcare resource allocation committees: lessons learned from assessing an Israeli case study.

Authors:  Yael Assor; Dan Greenberg
Journal:  BMC Health Serv Res       Date:  2022-06-02       Impact factor: 2.908

Review 2.  A systematic review of cost-sharing strategies used within publicly-funded drug plans in member countries of the organisation for economic co-operation and development.

Authors:  Lianne Barnieh; Fiona Clement; Anthony Harris; Marja Blom; Cam Donaldson; Scott Klarenbach; Don Husereau; Diane Lorenzetti; Braden Manns
Journal:  PLoS One       Date:  2014-03-11       Impact factor: 3.240

Review 3.  Setting healthcare priorities in hospitals: a review of empirical studies.

Authors:  Edwine W Barasa; Sassy Molyneux; Mike English; Susan Cleary
Journal:  Health Policy Plan       Date:  2014-03-05       Impact factor: 3.344

4.  Do the equity-efficiency preferences of the Israeli Basket Committee match those of Israeli health policy makers?

Authors:  Amir Shmueli
Journal:  Isr J Health Policy Res       Date:  2017-04-30

5.  Moving Towards Accountability for Reasonableness - A Systematic Exploration of the Features of Legitimate Healthcare Coverage Decision-Making Processes Using Rare Diseases and Regenerative Therapies as a Case Study.

Authors:  Monika Wagner; Dima Samaha; Roman Casciano; Matthew Brougham; Payam Abrishami; Charles Petrie; Bernard Avouac; Lorenzo Mantovani; Antonio Sarría-Santamera; Paul Kind; Michael Schlander; Michele Tringali
Journal:  Int J Health Policy Manag       Date:  2019-07-01

6.  Describing practices of priority setting and resource allocation in publicly funded health care systems of high-income countries.

Authors:  Brayan V Seixas; Dean A Regier; Stirling Bryan; Craig Mitton
Journal:  BMC Health Serv Res       Date:  2021-01-27       Impact factor: 2.655

7.  Which health technologies should be funded? A prioritization framework based explicitly on value for money.

Authors:  Ofra Golan; Paul Hansen
Journal:  Isr J Health Policy Res       Date:  2012-11-26

8.  Oncologists' and family physicians' views on value for money of cancer and congestive heart failure care.

Authors:  Dan Greenberg; Ariel Hammerman; Shlomo Vinker; Adi Shani; Yuval Yermiahu; Peter J Neumann
Journal:  Isr J Health Policy Res       Date:  2013-11-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.